US 9937228
Treatment of myocardial infarction by inhibiting the action of mAKAPβ
granted A61KA61K31/519A61K31/7048
Quick answer
US patent 9937228 (Treatment of myocardial infarction by inhibiting the action of mAKAPβ) held by Anchored RSK3 Inhibitors, LLC expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Anchored RSK3 Inhibitors, LLC
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/519, A61K31/7048, A61K31/713, A61K38/005